Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody

被引:41
作者
Kimata, H
Fujimoto, M
Ishioka, C
Yoshida, A
机构
[1] S KYOTO NATL HOSP,DEPT PEDIAT,KYOTO 61001,JAPAN
[2] SHIMADA MUNICIPAL HOSP,DEPT PEDIAT,SHIMADA,SHIZUOKA 427,JAPAN
[3] JAPANESE RED SOC WAKAYAMA MED CTR,DEPT PEDIAT,WAKAYAMA 640,JAPAN
关键词
D O I
10.1084/jem.184.2.357
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We studied the effects of histamine on human immunoglobulin (IgE) and IgG4 production. Histamine selectively enhanced IgE and IgG4 production in purified surface IgE and IgG4 negative (sIgE(-)sIgG4(-)) B cells from normal donors stimulated with interleukin (IL)-4 plus anti-CD58 or IL-13 plus anti-CD58 monoclonal antibody (mAb) without affecting production of IgG1, IgG2, IgG3. IgM, IgA1, or IgA2. In cultures with IL-4 plus anti-CD58 mAb, histamine-induced enhancement of IgE and IgG4 production was specifically blocked by thioperamide (H-3 receptor antagonist), and was inhibited by anti-IL-10 antibody (Ab). In contrast, in cultures with IL-13 plus anti-CD58 mAb, histamine-induced enhancement was blocked by dimaprit (H-1 receptor antagonist), and was inhibited by anti-IL-G mAb. Histamine also enhanced IgE and IgG4 production by in vivo-generated sIgE(+) and sIgG4(+) B cells, respectively, from atopic patients; enhancement was blocked by dimaprit and thioperamide, and was inhibited by anti-IL-6 mAb and anti-IL-10 Ab. In sIgE(-)sIgG4(-) B cells, IL-4 plus anti-CD58 mAb induced IL-10 production and IL-10 receptor expression, whereas IL-13 plus anti-CD58 mAb induced IL-6 production and IL-6 receptor expression. Histamine increased IL-10 and IL-G production without affecting IL-10 and IL-6 receptor expression, in cultures with IL-4 plus anti-CD58 mAb and with IL-13 plus anti-CD58 mAb. respectively, which was blocked by thioperamide and dimaprit, respectively. In contrast, sIgE(+) and sIgG4(+) B cells spontaneously produced both IL-6 and IL-10 and constitutively expressed IL-6 and IL-10 receptors, and histamine increased IL-6 and IL-10 production without affecting IL-6 or IL-10 receptor expression, which was blocked by thioperamide and dimaprit. These results indicate that histamine enhanced IgE and IgG4 production by increasing endogenous IL-6 and IL-10 production via H-1 and H-3 receptors, respectively.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 31 条
[1]
AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS [J].
AVERSA, G ;
PUNNONEN, J ;
COCKS, BG ;
MALEFYT, RD ;
VEGA, F ;
ZURAWSKI, SM ;
ZURAWSKI, G ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2213-2218
[2]
EFFECT OF SODIUM CROMOGLYCATE AND NEDOCROMIL SODIUM ON ANTI-IGE-INDUCED AND ANTI-IGG4-INDUCED BASOPHIL DE-GRANULATION [J].
BEAUVAIS, F ;
HIEBLOT, C ;
BENVENISTE, J .
DRUGS, 1989, 37 :4-8
[3]
HUMAN PERIPHERAL-BLOOD BASOPHILS PRIMED BY INTERLEUKIN-3 (IL-3) PRODUCE IL-4 IN RESPONSE TO IMMUNOGLOBULIN-E-RECEPTOR STIMULATION [J].
BRUNNER, T ;
HEUSSER, CH ;
DAHINDEN, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :605-611
[4]
INTERLEUKIN-13 STIMULATES INTERLEUKIN-6 PRODUCTION BY HUMAN KERATINOCYTES [J].
DEROCQ, JM ;
SEGUI, M ;
POINOTCHAZEL, C ;
MINTY, A ;
CAPUT, D ;
FERRARA, P ;
CASELLAS, P .
FEBS LETTERS, 1994, 343 (01) :32-36
[5]
DIAZSANCHEZ D, 1994, J IMMUNOL, V153, P10
[6]
INTERLEUKIN-9 POTENTIATES THE INTERLEUKIN-4-INDUCED IMMUNOGLOBULIN (IGG, IGM AND IGE) PRODUCTION BY NORMAL HUMAN B-LYMPHOCYTES [J].
DUGAS, B ;
RENAULD, JC ;
PENE, J ;
BONNEFOY, JY ;
PETIFRERE, C ;
BRAQUET, P ;
BOUSQUET, J ;
VANSNICK, J ;
MENCIAHUERTA, JM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1687-1692
[7]
FALUS A, 1993, IMMUNOLOGY, V78, P193
[8]
FALUS A, 1992, IMMUNOL TODAY, V13, P154
[9]
HISTAMINE INHIBITS IMMUNOGLOBULIN PRODUCTION VIA HISTAMINE H-2 RECEPTORS WITHOUT AFFECTING CELL-GROWTH IN HUMAN B-CELLS [J].
FUJIMOTO, M ;
KIMATA, H .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 73 (01) :96-102
[10]
GASCAN H, 1991, J IMMUNOL, V147, P8